Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/13/2009US20090202510 Altered sumoylation of lamin a protein associated with dilated cardiomyopathy
08/13/2009US20090202508 Negative regulation of hypoxia inducible factor 1 by os-9
08/13/2009US20090202507 Intelligent Nanomedicine Integrating Diagnosis And Therapy
08/13/2009US20090202505 Rescue of Photoreceptors by Intravitreal Administration of an Expression Vector Encoding a Therapeutic Protein
08/13/2009US20090202504 Methods for the detection and prognosis of breast tumors
08/13/2009US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof
08/13/2009US20090202502 Hepatic stellate cell specific promoter and uses thereof
08/13/2009US20090202491 Method for modulating, regulating and/or stabilizing angiogenesis
08/13/2009US20090202488 Use Of The Foamy Virus Bet Protein For Inactivating APOBEC
08/13/2009US20090202484 Modulators of toll-like receptor 7
08/13/2009US20090202483 Hepatitis C Virus Inhibitors
08/13/2009US20090202480 Macrocyclic serine protease inhibitors
08/13/2009US20090202478 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials
08/13/2009US20090202476 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
08/13/2009US20090202475 Compositions and methods for treatment of microbial disorders
08/13/2009US20090202471 Molecules with effects on cellular development and function
08/13/2009US20090202470 Phosphonate Analogs of Hiv Inhibitor Compounds
08/13/2009US20090202467 Sclerotherapy for varicose veins
08/13/2009US20090202463 Antimicrobial compositions, products and methods employing same
08/13/2009US20090202457 Method for exfoliating skin
08/13/2009US20090202456 Novel salts and their uses
08/13/2009US20090202449 Use of osteopontin in dental formulations
08/13/2009US20090202448 Metal lactate powder and method for preparation
08/13/2009US20090202445 Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children.
08/13/2009US20090202443 Methods of improving skin quality
08/13/2009US20090202442 Enerceutical activation of the alternative cellular energy (ACE) pathway in therapy of diseases
08/13/2009US20090202439 Methods for treatment of angiogenesis
08/13/2009US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases
08/13/2009US20090202436 Bupivacaine Formulation in a Polyorthoester Carrier
08/13/2009US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors
08/13/2009US20090200185 Systems and methods for administering a medical regimen
08/13/2009DE69322992C5 Optisch reines Cis-oxalato(trans-l-1,2-Cyclohexandiamine)Pt(II) und Verfahren zur Auflösung von optischen Isomeren einer Platinkomplexverbindung Optically pure cis-oxalato (trans-l-1,2-Cyclohexandiamine) Pt (II) and methods for the resolution of optical isomers of a platinum complex compound
08/13/2009DE202009006461U1 Kombination von Tocotrienolen mit ungesättigten Fettsäuren als Mittel zum Schutz des Herz/Kreislaufsystems, vor Krebserkrankungen, zur Entzündungshemmung, zur Steigerung der geistigen Leistungsfähigkeit und gegen Altersbeschwerden Combination of tocotrienols with unsaturated fatty acids as a means to protect the heart / circulatory system against cancer, reduces inflammation, increase mental performance and complaints against age
08/13/2009DE102008008554A1 Kosmetische oder medizinische Zubereitung enthaltend Biotin Cosmetic or medicinal preparation containing biotin
08/13/2009DE102008008497A1 Produkt aus O-acylierter Hydroxycarbonsäure und Aminosäure, ihre Herstellung, biologische Aktivitäten, kosmetisch oder pharmazeutisch wirksame Zusammensetzungen sowie Verwendung derselben insbesondere als Lebensmittelzusatzstoff und als Kosmetikzusatzstoff Product of O-acylated amino acid and hydroxycarboxylic acid, their preparation and biological activities, cosmetically or pharmaceutically effective compositions, and use thereof in particular, as a food additive and as a cosmetic additive
08/13/2009DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs
08/13/2009DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases
08/13/2009DE102008007198A1 Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften Orally or nasally administered epinephrine-containing formulations with improved properties
08/13/2009DE102004034747B4 Salbenzubereitung geeignet bei neurodermitischen Hauterkrankungen Ointment formulation suitable for neurodermatitis skin diseases
08/13/2009CA2828861A1 Oral care product and methods of use and manufacture thereof
08/13/2009CA2724230A1 Platinum aggregates and process for producing the same
08/13/2009CA2722536A1 Prodrugs of cgrp receptor antagonist
08/13/2009CA2715483A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes
08/13/2009CA2715353A1 Use of picoplatin and cetuximab to treat colorectal cancer
08/13/2009CA2715329A1 Picoplatin and amrubicin to treat lung cancer
08/13/2009CA2715266A1 Inhibition and treatment of gastrointestinal biofilms
08/13/2009CA2715260A1 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
08/13/2009CA2715143A1 Novel phenylpyrrole derivative
08/13/2009CA2715127A1 Siva3, its preparation and use
08/13/2009CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure
08/13/2009CA2714966A1 Arylmethylidene heterocycles as novel analgesics
08/13/2009CA2714516A1 Abca-1 elevating compounds and the use thereof
08/13/2009CA2714480A1 3,8-diaminotetrahydroquinoline derivative
08/13/2009CA2714426A1 Methods and compositions for treating respiratory disease
08/13/2009CA2714420A1 Phosphate derivatives of substituted benzoxazoles
08/13/2009CA2714419A1 Dual pharmacophores - pde4-muscarinic antagonistics
08/13/2009CA2714418A1 Dual pharmacophores - pde4 -muscarinic antagonistics
08/13/2009CA2714410A1 Disease markers and uses thereof
08/13/2009CA2714398A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
08/13/2009CA2714389A1 Macrolides and uses of macrolides
08/13/2009CA2714370A1 Compounds that enhance atoh-1 expression
08/13/2009CA2714352A1 Dual pharmacophores-pde4-muscarinic antagonistics
08/13/2009CA2714350A1 Substituted piperidines as renin inhibitors
08/13/2009CA2714347A1 Substituted piperidines as renin inhibitors
08/13/2009CA2714272A1 Therapeutic treatment for lung conditions
08/13/2009CA2714237A1 Immunosuppressive macrolide powder for oral suspension
08/13/2009CA2714232A1 Pyridinyl amides for the treatment of cns and metabolic disorders
08/13/2009CA2714231A1 Topical antimicrobial compositions
08/13/2009CA2714226A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/13/2009CA2714200A1 Method for improving storage stability of glutathione
08/13/2009CA2714181A1 Ampk modulators
08/13/2009CA2714177A1 Pyrrolo [2,3-d] pyridines and use thereof as tyrosine kinase inhibitors
08/13/2009CA2714113A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
08/13/2009CA2714112A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
08/13/2009CA2714043A1 Methods and compositions for treating inflammatory bowel disease
08/13/2009CA2713958A1 Substituted cyclopentanes having prostaglandin activity
08/13/2009CA2713943A1 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
08/13/2009CA2713899A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird
08/13/2009CA2713864A1 Certain chemical entities, compositions and methods
08/13/2009CA2713855A1 Benzylpiperizine compound
08/13/2009CA2713849A1 Crosslinked polysaccharides and methods of production thereof
08/13/2009CA2713848A1 Anti-influenza compounds
08/13/2009CA2713770A1 Methods of treating skin with aromatic skin-active ingredients
08/13/2009CA2713768A1 Substituted furans and use thereof
08/13/2009CA2713554A1 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments
08/13/2009CA2713551A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/13/2009CA2713550A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
08/13/2009CA2713547A1 Biaryl amides
08/13/2009CA2713521A1 Use of ranolazine for treating pain
08/13/2009CA2713447A1 Extended release hydrocodone acetaminophen and related methods and uses thereof
08/13/2009CA2713438A1 Treatment of bladder diseases with a tlr7 activator
08/13/2009CA2713409A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
08/13/2009CA2713380A1 Compositions of phytosterols with enhanced bioavailability
08/13/2009CA2713377A1 Protective effect of high dose folate on mycardial ischemia
08/13/2009CA2713361A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
08/13/2009CA2713322A1 Compounds
08/13/2009CA2713173A1 (dihydro)pyrrolo[2,1-.alpha.]isoquinolines
08/13/2009CA2712971A1 Macrocyclic serine protease inhibitors
08/13/2009CA2712858A1 Novel process for the preparation of vorinostat
08/13/2009CA2712800A1 Compositions and methods for alleviating depression or improving cognition